Chemycal has been acquired by 3E

Learn More
  • January 21, 2025
  • 3E

Combatting Substances of Very High Concern (SVHCs)


Your substances

None


As global regulatory frameworks continue to evolve, the focus on Substances of Very High Concern (SVHCs) has intensified. These chemicals, identified as posing serious risks to human health or the environment, are subject to strict controls under regulations such as the European Union’s REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals) framework. For businesses that manufacture, import, or use chemicals, understanding and managing SVHCs is crucial for regulatory compliance and protecting the public and the environment. In this article, we’ll explore what businesses need to know about SVHCs, the challenges they present, and how companies can manage their risks effectively.

What Are Substances of Very High Concern (SVHCs)?

SVHCs are chemicals that have been identified as posing significant hazards. The criteria for identifying a substance as an SVHC are outlined under REACH and include:

  • Carcinogenic, Mutagenic, or Reproductive Toxicity (CMR): These substances can cause cancer, genetic mutations, or harm reproductive health.
  • Persistent, Bioaccumulative, and Toxic (PBT): These chemicals degrade slowly, accumulate in living organisms, and are toxic to the environment.
  • Very Persistent and Very Bioaccumulative (vPvB): Similar to PBT substances, these chemicals are highly resistant to degradation and accumulate in the environment.
  • Endocrine Disruptors: These substances can interfere with the hormonal systems of humans and animals, causing developmental, reproductive, or other health issues.

Once a substance is identified as an SVHC, it may be placed on the Candidate List under REACH. If further assessment determines that the risks cannot be adequately controlled, the substance may be included on the Authorization List, requiring companies to seek permission before continuing to use it.

CONTINUE READING ON: www.3eco.com

                   

Related News

Loading...